Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06383858 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Project of Gestational Hypertension and Preeclampsia Screening and Prevention Center

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Interventions: Screening method (Diagnostic Test), Screening method (Diagnostic Test)
    • Eligibility criteria expanded, about 16 words
    • Study description expanded, about 6 words
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Preeclampsia is the main cause of illness and death in pregnant women and fetuses. Currently, there is no effective treatment for preeclampsia in clinical practice, and the fundamental treatment is still termination of pregnancy and placental delivery. Therefore, early prediction of preeclampsia and targeted strengthening of high-risk pregnant women supervision, early intervention and diagnosis and treatment can greatly reduce the serious obstetric complications and perinatal maternal and fetal deaths caused by preeclampsia, which has significant social and clinical significance.
Trial Details
NCT Number NCT06383858
Lead Sponsor The Third Affiliated Hospital of Guangzhou Medical University
Conditions
(from sponsor)		 Preeclampsia, Maternal Deaths
Related terms Maternal Death, Pre-Eclampsia
Enrollment 50,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov